Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Water Tower Research Publishes Initiation of Coverage Report on Ingevity Corporation, "High-Margin Carbon Franchise Riding a Structural Shift to Hybrids with PFAS Upside"
November 17, 2026
Via
TheNewswire.com
Topics
Emissions
Energy
Product Recall
Tickers
ASX:TWR
NGVT
Exposures
Fossil Fuels
Legal
Product Safety
Insight Molecular (IMDX) Q3 2026 Earnings Call Transcript
↗
November 17, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
IMDX
Exposures
Financial
Product Safety
ReposiTrak (TRAK) Q1 2027 Earnings Call Transcript
↗
November 17, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
TRAK
Exposures
Financial
Product Safety
Generalized Myasthenia Gravis Treatment Market to Reach US$11.1 Billion by 2035 | FDA Approval of Klygefa Adds a Convenience-Led Competitive Dimension
November 17, 2026
Via
Press Release Distribution Service
Exposures
Product Safety
What NRx Pharmaceuticals (NRXP) Said on Its Q3 Earnings Call
↗
November 17, 2026
Via
MarketBeat
Topics
Earnings
Tickers
NRXP
Exposures
Financial
Product Safety
BioMedNewsBreaks – Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Schedules Dec. 10 Investor Call to Discuss Cardiovascular Testing and FDA Designation Plans
November 17, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Tickers
CDIO
Exposures
Artificial Intelligence
Product Safety
BioCorRx Files Q3 2026 Form 10-Q and Highlights Key Commercial, Clinical, Intellectual Property, and Governance Milestones
November 17, 2026
Via
NewMediaWire
Topics
Intellectual Property
Tickers
BICX
Exposures
Intellectual Property
Product Safety
Cytokinetics Touts MYQORZO Launch Momentum, Plans New FDA Filing
↗
November 17, 2026
Via
MarketBeat
Tickers
CYTK
UBS
Exposures
Product Safety
Ultragenyx Pharmaceutical Targets 2027 Profitability After Deep Cuts and Gene Therapy Launches
↗
November 17, 2026
Via
MarketBeat
Tickers
RARE
UBS
Exposures
Product Safety
Solid Biosciences Eyes FDA Fast-Track Path for Duchenne Gene Therapy, Potential 2027 Filing
↗
November 17, 2026
Via
MarketBeat
Tickers
SLDB
Exposures
Product Safety
United Therapeutics Prepares for TYVASO Expansion After $833 Million Quarter
↗
November 16, 2026
Via
MarketBeat
Tickers
UBS
UTHR
Exposures
Product Safety
Aquestive Therapeutics Eyes Needle-Free Allergy Treatment Launch Ahead of 2027 FDA Decision
↗
November 16, 2026
Via
MarketBeat
Tickers
AQST
Exposures
Product Safety
What Oncocyte (IMDX) Said on Its Q3 Earnings Call
↗
November 16, 2026
Via
MarketBeat
Topics
Earnings
Tickers
IMDX
Exposures
Financial
Product Safety
ReposiTrak Q1 Earnings Call Highlights
↗
November 16, 2026
Via
MarketBeat
Topics
Earnings
Tickers
TRAK
Exposures
Financial
Product Safety
Oncosoft named to the 2026 CB Insights’ 50 most promising digital health startups
November 16, 2026
Via
Get News
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Unicycive Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update
November 16, 2026
Via
B2i Digital
Tickers
UNCY
Exposures
Product Safety
King Cake's Evolution From Sweet to Savory: Caluda's Shares New Report
November 16, 2026
Via
Press Release Distribution Service
Topics
Product Recall
Exposures
Legal
Product Safety
Verastem Weighs Partnership or Solo Launch as Cancer Drug Trials Advance
↗
November 16, 2026
Via
MarketBeat
Tickers
VSTM
Exposures
Product Safety
Lexeo Therapeutics Q3 Earnings Call Highlights
↗
November 16, 2026
Via
MarketBeat
Topics
Earnings
Tickers
LXEO
Exposures
Financial
Product Safety
Summit Crumbles After FDA Rejects Merck-Rivaling Lung Cancer Drug
↗
November 16, 2026
Via
Investor's Business Daily
Exposures
Product Safety
BioMarin Pharmaceutical Sees $2.6 Billion Sales Potential in Amicus Drugs as VOXZOGO Expansion Looms
↗
November 16, 2026
Via
MarketBeat
Tickers
BMRN
UBS
Exposures
Product Safety
Vertex Pharmaceuticals Prepares for Key Kidney Drug Decision as Pipeline Readouts Loom
↗
November 16, 2026
Via
MarketBeat
Tickers
UBS
VRTX
Exposures
Product Safety
Owlet: 3 Key Takeaways for Long-Term Investors
↗
November 16, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
AMZN
OWLT
Exposures
Financial
Product Safety
Considering SMILE Eye Surgery? What to Know Before You Book a Consultation
November 16, 2026
Via
Worldnewswire
Exposures
Product Safety
CCHR Demands Oversight of Elderly Drugging and Protection from Electroshock
November 16, 2026
Via
24-7 Press Release
Exposures
Product Safety
Navigating the Unpredictable Ride of COPD
November 16, 2026
Via
NewsUSA
Topics
Product Recall
Exposures
Legal
Product Safety
FDA Doesn't Approve Summit's China-Developed Lung Cancer Drug
↗
November 15, 2026
Via
Investor's Business Daily
Exposures
Product Safety
Natera CFO Maps Multiple Paths to $6 Billion Revenue Target by 2029
↗
November 15, 2026
Via
MarketBeat
Tickers
NTRA
UBS
Exposures
Product Safety
Food Plant Cleaning Services Expands 24/7 Emergency Response Capability for Contamination Events
November 13, 2026
Via
Press Advantage
Exposures
Product Safety
uniQure CEO Defends Huntington’s Therapy Data, Sees Opportunity Ahead of FDA Decision
↗
November 13, 2026
Via
MarketBeat
Tickers
QURE
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.